| (11-beta,16-beta)-9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione |
| (11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate |
| (11beta,16beta)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate |
| (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthr |
| [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate |
| [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate |
| 2-((2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-2,13,15-trimethyl-5-oxo -14-propanoyloxytetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl)-2-o xoethyl propanoate |
| 2-[(1R,2S,10S,11S,13S,14R,15S,17S)-1-FLUORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXO-14-(PROPANOYLOXY)TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL PROPANOATE |
| 5593-20-4 |
| 826Y60901U |
| 9-Fluoro-11.beta.-hydroxy-16.beta.-methyl-3,20-dioxo-17-(propionyloxy)pregna-1,4-dien-21-yl propionate # |
| 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate |
| 9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate |
| 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate) |
| 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate |
| 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate |
| 9alpha-Fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17,21-Dipropionate |
| AB01274713_02 |
| AB01274713-01 |
| AB2000220 |
| AC1L2J44 |
| AKOS015969733 |
| Alphatrex |
| AN-14216 |
| B3166 |
| BDBM50421892 |
| Beloderm |
| beta-Methasone 17,21-dipropionate |
| Betamethasone 17,21-dipropionate |
| BETAMETHASONE DIPROP |
| betamethasone dipropionat |
| BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate (Diprolene) |
| Betamethasone dipropionate (JP17/USP) |
| Betamethasone dipropionate [USAN:BAN:JAN] |
| Betamethasone dipropionate [USAN:USP:JAN] |
| Betamethasone-17,21-dipropionate |
| Betamethasone17,21-dipropionate |
| Bio-0632 |
| BRN 3638108 |
| C-22966 |
| C28H37FO7 |
| CAS-5593-20-4 |
| CC-24614 |
| CHEBI:31276 |
| CHEMBL1200384 |
| CIWBQSYVNNPZIQ-XYWKZLDCSA-N |
| component of Alphatrex (Salt/Mix) |
| component of Betasone (Salt/Mix) |
| CS-7549 |
| D01637 |
| Diproderm |
| Diprolene |
| Diprolene AF |
| Diprosis |
| Diprosone |
| Diprospan;Diprolene;Diprosone;Diprolene AF;Diprolene |
| DR003077 |
| DSSTox_CID_2672 |
| DSSTox_GSID_22672 |
| DSSTox_RID_76683 |
| DTXSID2022672 |
| EBD2157850 |
| EINECS 227-005-2 |
| en-17-yl propionate |
| HY-13571 |
| KS-5303 |
| LS-118474 |
| Maxivate |
| MolPort-002-515-791 |
| NCGC00159360-02 |
| NCGC00159443-02 |
| PL059578 |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11-.beta.,17,21-trihydroxy-16-.beta.-methyl-,17,21-dipropionate |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 17,21-dipropionate |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-,17,21-dipropionate |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl- 17,21-bis(1-oxopropoxy)-, (11ss,16ss)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11.beta.,16.beta.)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta) |
| Psorion |
| Rinderon DP |
| Rinderon-DP (TN) |
| S 3440 |
| S-3440 |
| s1688 |
| Sch 11460 |
| Sch-11460 |
| SCHEMBL7519 |
| Sernivo (TN) |
| ST024761 |
| Tox21_113343 |
| UNII-826Y60901U |
| ZINC4212137 |
